
Bo Chen
Articles
-
2 months ago |
arxiv.org | Bo Chen |Xiaoyu Li |Yingyu Liang |Zhizhou Sha
-
2 months ago |
pubs.acs.org | Yilin Cao |Zhixiang Zhang |Tao Yu |Bo Chen
-
2 months ago |
dx.doi.org | Yilin Cao |Zhixiang Zhang |Tao Yu |Bo Chen
-
Jan 6, 2025 |
thelancet.com | Sun Yat-sen |KYM Biosciences |Bo Chen
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial - The Lancet Oncology
-
Dec 27, 2024 |
mdpi.com | Bo Chen
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Guixiang Yi 1,†, Yuanyuan Song 2,†, Jian Wang 3,* and Bo Chen 2 1Inspection and Certification Co., Ltd. MCC, Beijing 100088, China 2School of Civil Engineering, Beijing Jiaotong University, Beijing 100044, China 3School of Civil Engineering, Sun Yat-Sen University, Guangzhou 510275, China *Author to whom correspondence should be addressed.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →